Abivax SA - American Depositary Shares (NQ:ABVX)

146.63 +8.28 (+5.99%)

Streaming Delayed Price Updated: 10:49 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	483,877
Open	140.67
Bid (Size)	146.50 (100)
Ask (Size)	146.77 (200)
Prev. Close	138.35
Today's Range	140.67 - 148.83
52wk Range	4.770 - 142.49
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗

Today 4:01 EST

A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality.

Via Stocktwits

Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗

Today 3:45 EST

Markets are moving from a record-setting close into a thin, holiday-shortened Christmas Eve session.

Via Stocktwits

Performance

YTD	+1911.5%	+1911.5%
1 Month	+16.6%	+16.6%
3 Month	+78.8%	+78.8%
6 Month	+2105.0%	+2105.0%
1 Year	+1895.0%	+1895.0%

More News

The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave

December 23, 2025

Via MarketMinute

Why Abivax Stock Was on Fire Today ↗

December 22, 2025

Via The Motley Fool

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗

December 22, 2025

Via The Motley Fool

Abivax to be Added to Nasdaq Biotechnology Index

December 18, 2025

From Abivax

Via GlobeNewswire

The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains

December 18, 2025

Via MarketMinute

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

December 17, 2025

From Abivax

Via GlobeNewswire

Abivax Presents Third Quarter 2025 Financial Results

December 15, 2025

From Abivax

Via GlobeNewswire

2 Under-the-Radar Stocks That Have Soared This Year ↗

December 09, 2025

Via The Motley Fool

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

November 06, 2025

Via Benzinga

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

November 03, 2025

From Abivax

Via GlobeNewswire

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

AMD To Rally More Than 47%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 07, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Why Is Abivax Stock Trading Higher On Monday? ↗

October 06, 2025

Via Benzinga

Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease ↗

October 06, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?

Yes, Abivax SA - American Depositary Shares is publicly traded.

What exchange does Abivax SA - American Depositary Shares trade on?

Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Abivax SA - American Depositary Shares?

The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market

What is the current price of Abivax SA - American Depositary Shares?

The current price of Abivax SA - American Depositary Shares is 146.63

When was Abivax SA - American Depositary Shares last traded?

The last trade of Abivax SA - American Depositary Shares was at 12/24/25 10:49 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.